Reduced red cell transfusions and hospitalizations in sickle cell patients treated with voxelotor-Experience from a single center
Transfusion
.
2022 Jul;62(7):1462-1464.
doi: 10.1111/trf.16989.
Authors
Najeebah A Bade
1
,
Upama Giri
1
,
Hongkun Wang
2
,
William B Ershler
1
Affiliations
1
Adult Sickle Center, Inova Schar Cancer Institute, Fairfax, Virginia, USA.
2
Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University Medical Center, Washington, District of Columbia, USA.
PMID:
35815728
DOI:
10.1111/trf.16989
No abstract available
Publication types
Letter
Comment
MeSH terms
Anemia, Sickle Cell* / therapy
Antisickling Agents
Benzaldehydes*
Hospitalization
Humans
Pyrazines
Pyrazoles
Substances
Antisickling Agents
Benzaldehydes
Pyrazines
Pyrazoles
voxelotor